bioAffinity Technologies (BIAF) Preferred Stock Liabilities (2021)
bioAffinity Technologies (BIAF) posted quarterly Preferred Stock Liabilities of $4.0 million for Q4 2021.
bioAffinity Technologies (BIAF) Preferred Stock Liabilities (2021) Analysis & Trends
bioAffinity Technologies (BIAF) has reported Preferred Stock Liabilities for 1 consecutive years, with $4.0 million the latest figure, recorded in Q4 2021.
- In Q4 2021, Preferred Stock Liabilities changed N/A year-over-year to $4.0 million; the TTM figure through Dec 2021 stood at $4.0 million (changed N/A YoY), while the FY2021 annual figure was $4.0 million, changed N/A from the prior year.
- Preferred Stock Liabilities steadied at $4.0 million in Q4 2021 per BIAF's latest filing.
- Across five years, Preferred Stock Liabilities topped out at $4.0 million in Q4 2021 and bottomed at $4.0 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | - |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | - |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | - |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | - |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | - |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | - |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | - |
| 10 | bioAffinity Technologies | 2.38 Mn | -721,990.64 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 4.04 Mn |